Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
Release Date:
Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology. Read the full article:The Boston criteria version 2.0 for cerebral amyloid angiopathyContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy